APOS
Apollo Global Management, Inc.
$25.99
+0.74%
$14.7B
No data for this timeframe.
Vol
Market Cap$14.7B
Cap SizeLarge Cap
SEC Reports3
Recent Activity
May 15, 2026
SEC
Apollo Global Management filed an 8-K announcing that its subsidiary, Athene Holding Ltd., will host a Fixed Income Inve
8-K — Impact 2/10
Apr 24, 2026
SEC
Apollo Global Management, Inc. (APOS) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, sche
DEFA14A — Impact 2/10
Apr 21, 2026
SEC
Apollo Global Management issued a preliminary update for Q1 2026, estimating $205 million in alternative net investment
8-K — Impact 6/10
Analyst Ratings
5Strong Buy
13Buy
5Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
2/10
Apollo Global Management filed an 8-K announcing that its subsidiary, Athene Holding Ltd., will host a Fixed Income Inve
May 15, 2026
NEUTRAL
DEFA14A
2/10
Apollo Global Management, Inc. (APOS) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, sche
Apr 24, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 3.3/10.
NEUTRAL
8-K
2/10
Apollo Global Management filed an 8-K announcing that its subsidiary, Athene Holding Ltd., will host
May 15, 2026
NEUTRAL
DEFA14A
2/10
Apollo Global Management, Inc. (APOS) has filed a definitive proxy statement (DEFA14A) for its 2026
Apr 24, 2026
BEARISH
8-K
6/10
Apollo Global Management issued a preliminary update for Q1 2026, estimating $205 million in alterna
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 78% buy across 23 analysts — 5 strong buy, 13 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 5 | 13 | 5 | 0 | 0 | 78% | |
| Apr 1, 2026 | 5 | 13 | 5 | 0 | 0 | 78% | |
| Mar 1, 2026 | 5 | 13 | 5 | 0 | 0 | 78% | |
| Feb 1, 2026 | 5 | 13 | 5 | 0 | 0 | 78% | |
| Jan 1, 2026 | 5 | 13 | 5 | 0 | 0 | 78% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.